20th Global Site Solutions Summit 2026

活動詳細資訊:

Strong site relationships are essential to successful clinical trials. Novotech will be at the Global Site Solutions Summit 2026 to connect with research sites, investigators and research networks** and discuss how we can work together to make studies easier to start and deliver.

With experience across more than 7,260 trial sites globally, our teams understand the realities sites face and the importance of clear communication, practical study planning and strong collaboration throughout a trial.

Meet our team:

• Terra Johnston, Director Regulatory Operations
• Julie Wilhjelm, Senior Director Site Engagement & Feasibility
• Kettrina Mosby, Senior Director Centralised Feasibility & Operational Strategy
• Allyson Cygnarowicz, Senior Director Clinical Operations

Panel Discussion: Myth Busters: GCP R3 Implementation

Terra Johnston will join the panel on Saturday, October 17, from 11:30 a.m. - 12:30 p.m. to separate GCP R3 requirements from common sponsor and CRO interpretations, address common activation delays and understand. The discussion will look at areas that can contribute to activation delays and how documented SOPs can help sites approach implementation with greater clarity and confidence.

Visit Booth 320 to meet the Novotech team.